Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × Vinorelbine × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 7 Triple Negative Breast Neoplasms 4 Rhabdomyosarcoma 4 Hodgkin Disease 4 Recurrence 3 Uterine Cervical Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Adenocarcinoma 2 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 NSCLC 1 Mesothelioma, Malignant 1 Lung Diseases, Interstitial 1 Locally Advanced Non-Small Cell Lung Cancer 1 HR+HER2- Breast Cancer 1 HER2-negative Metastatic Breast Cancer 1 Fludzoparib" and Anti-angiogenic 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1 Advanced Breast Cancer 1

Interventions

venetoclax 61 Cyclophosphamide 51 ibrutinib 46 obinutuzumab 42 acalabrutinib 41 Rituximab 40 fludarabine 32 fludarabine phosphate 27 Specimen Handling 25 zanubrutinib 24 pirtobrutinib 23 Biopsy 22 Whole-Body Irradiation 16 Bendamustine Hydrochloride 16 Mycophenolic Acid 13 Magnetic Resonance Spectroscopy 13 Lenalidomide 12 Tacrolimus 8 Sirolimus 7 Peripheral Blood Stem Cell Transplantation 7 idelalisib 6 Prednisone 6 Melphalan 6 CT-P10 6 Busulfan 6 tafasitamab 5 pembrolizumab 5 ofatumumab 5 Stem Cell Transplantation 5 Etoposide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡